Outcome measures for Charcot-Marie-Tooth disease: clinical and neurofunctional assessment in children.
about
Vincristine-induced peripheral neuropathy in pediatric cancer patientsChanges of gait pattern in children with Charcot-Marie-Tooth disease type 1A: a 18 months follow-up study.Transitioning outcome measures: relationship between the CMTPedS and CMTNSv2 in children, adolescents, and young adults with Charcot-Marie-Tooth disease.Intensive strength and balance training with the Kinect console (Xbox 360) in a patient with CMT1A.Nine-hole Peg Test and Ten-meter Walk Test for Evaluating Functional Loss in Chinese Charcot-Marie-Tooth DiseaseNatural history of Charcot-Marie-Tooth disease during childhood.
P2860
Outcome measures for Charcot-Marie-Tooth disease: clinical and neurofunctional assessment in children.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on September 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Outcome measures for Charcot-M ...... tional assessment in children.
@en
Outcome measures for Charcot-M ...... tional assessment in children.
@nl
type
label
Outcome measures for Charcot-M ...... tional assessment in children.
@en
Outcome measures for Charcot-M ...... tional assessment in children.
@nl
prefLabel
Outcome measures for Charcot-M ...... tional assessment in children.
@en
Outcome measures for Charcot-M ...... tional assessment in children.
@nl
P2093
P2860
P1476
Outcome measures for Charcot-M ...... tional assessment in children.
@en
P2093
Alessia Marchi
Anita Magro
Davide Pareyson
Emanuela Pagliano
Giovanni Baranello
Maurizio Ferrarin
Sara Bulgheroni
P2860
P304
P356
10.1111/J.1529-8027.2011.00357.X
P577
2011-09-01T00:00:00Z